Search clinical trials for: Relapsed CLL

Total 7091 results

MingSight Pharmaceuticals, Inc

Not yet recruiting

A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL

CLL (Chronic Lymphocytic Leukemia) | SLL (Small Lymphocytic Lymphoma)
BeOne Medicines
German CLL Study Group

Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

Canada, United States, Spain, China, Germany, New Zealand, United Kingdom, Denmark, Italy, Belgium, France, Ireland, Austria, Sweden, Netherlands, Australia, Poland, Brazil, South Korea, Argentina, Czechia
Vitebsk Regional Clinical Cancer Centre
Republican Scientific and Practical Center for children's Oncology, Hematology...

Recruiting

Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients. (VTB-CLL002)

Small Lymphocytic Lymphoma (SLL) | Chronic Lymphocytic Leukaemia (CLL)

Belarus
Stichting Hemato-Oncologie voor Volwassenen Nederland
German CLL Study Group; Nordic CLL Study Group

Recruiting

Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLL (AETHER)

CLL/SLL

Netherlands, Denmark, Belgium, Germany
Xinqiao Hospital of Chongqing
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Not yet recruiting

Dual CD33-CLL1-CAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Leukemia, Myeloid, Acute

China

Search clinical trials for: Relapsed CLL

This is a preview